Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec;29(12):7289-7297.
doi: 10.1007/s00520-021-06311-9. Epub 2021 May 25.

Fear of cancer recurrence in patients undergoing germline genome sequencing

Nicci Bartley  1 , Grace Davies  2 , Phyllis Butow  2 , Christine E Napier  3 , Tim Schlub  2 , Mandy L Ballinger  3   4 , David M Thomas  3   4 , Ilona Juraskova  2 , Bettina Meiser  5 , Megan C Best  2   6
Affiliations

Fear of cancer recurrence in patients undergoing germline genome sequencing

Nicci Bartley et al. Support Care Cancer. 2021 Dec.

Abstract

Purpose: Fear of cancer recurrence/occurrence (FCR/O) is prevalent and associated with poorer psychological outcomes but can also motivate individuals to pursue genomic information about cancer risk. Guided by Protection Motivation Theory, this study investigated FCR/O prevalence and associated factors among probands previously diagnosed with a cancer of likely heritable origin, and their relatives, who had agreed to have germline genome sequencing.

Methods: Three hundred and forty-eight probands and 167 relatives completed the Concerns about Recurrence Questionnaire (adapted for occurrence for some relatives) within 1 month of agreeing to undertake genome sequencing. Linear regressions investigated demographic, disease, attitude and behavioral associations with FCR/O.

Results: Probands demonstrated greater FCR compared to relatives. In probands, greater FCR was associated with being female, non-English speaking at home, less time since diagnosis, greater intention to change behavior if gene variant found, lower perceived ability to cope with results, higher perceived susceptibility to having a recurrence, and more negative attitudes towards uncertainty. For relatives with cancer, greater FCR was associated with being male, greater intention to change behavior if a gene variant found, and higher perceived susceptibility to recurrence. In relatives without cancer, greater FCO was associated with not having had genetic testing prior to this study, lower perceived ability to cope with results, and higher perceived susceptibility to developing cancer.

Conclusion: Current findings on FCR/O prevalence and associated demographic and attitudinal variables in those who pursue genomic risk information might be used to target interventions that can prevent adverse psychological outcomes in vulnerable patients.

Keywords: Cancer; Fear of cancer recurrence; Genomics; Oncology; Psycho-oncology; Risk.

PubMed Disclaimer

References

    1. Simard S, Thewes B, Humphris G, Dixon M, Hayden C, Mireskandari S et al (2013) Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies. J Cancer Surviv 7(3):300–322 - DOI
    1. Mellon S, Gold R, Janisse J, Cichon M, Tainsky MA, Simon MS et al (2008) Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer. Psychooncology 17(8):756–766 - DOI
    1. Lebel S, Maheu C, Tomei C, Bernstein LJ, Courbasson C, Ferguson S et al (2018) Towards the validation of a new, blended theoretical model of fear of cancer recurrence. Psychooncology 27(11):2594–2601 - DOI
    1. Thewes B, Meiser B, Hickie IB (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10(6):459–468 - DOI
    1. Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M et al (2002) Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 38(15):2025–2031 - DOI

LinkOut - more resources